{"result": "(\"entity\"<|>ANEMIA FERROPÉNICA<|>EVENT<|>Anemia ferropénica is a condition characterized by a deficiency of iron, leading to a decrease in hemoglobin levels and affecting the body's ability to transport oxygen.)\n##\n(\"entity\"<|>H. PYLORI<|>ORGANIZATION<|>H. pylori is a type of bacteria that can infect the stomach and is often associated with various gastrointestinal diseases, including ulcers and gastritis.)\n##\n(\"entity\"<|>FERRITINA<|>ORGANIZATION<|>Ferritina is a protein that stores iron in the body and releases it in a controlled fashion, playing a crucial role in iron metabolism.)\n##\n(\"entity\"<|>SULFATO FERROSO<|>ORGANIZATION<|>Sulfato ferroso is a common iron supplement used to treat iron deficiency anemia, particularly in its oral form.)\n##\n(\"entity\"<|>ÁCIDO FÓLICO<|>ORGANIZATION<|>Ácido fólico is a B-vitamin that is important for the production of red blood cells and is often recommended as a supplement in cases of anemia.)\n##\n(\"entity\"<|>TOMOGRAFÍA COMPUTARIZADA<|>EVENT<|>Tomografía computarizada is a medical imaging technique used to obtain detailed images of internal structures, often used in the diagnosis of various conditions.)\n##\n(\"entity\"<|>FIBROGASTROSCOPIA<|>EVENT<|>Fibrogastroscopia is a procedure that allows doctors to examine the upper digestive tract using a flexible tube with a camera, often used to diagnose gastrointestinal issues.)\n##\n(\"entity\"<|>FIBROCOLONOSCOPIA<|>EVENT<|>Fibrocolonoscopia is a procedure used to examine the colon and rectum for abnormalities, often used in the diagnosis of colorectal diseases.)\n##\n(\"relationship\"<|>ANEMIA FERROPÉNICA<|>FERRITINA<|>Ferritina is crucial for diagnosing and managing anemia ferropénica as it indicates the body's iron stores<|>8)\n##\n(\"relationship\"<|>ANEMIA FERROPÉNICA<|>SULFATO FERROSO<|>Sulfato ferroso is commonly prescribed to treat anemia ferropénica by replenishing iron levels<|>9)\n##\n(\"relationship\"<|>ANEMIA FERROPÉNICA<|>ÁCIDO FÓLICO<|>Ácido fólico is recommended as a supplement to support recovery from anemia ferropénica<|>7)\n##\n(\"relationship\"<|>H. PYLORI<|>FIBROGASTROSCOPIA<|>Fibrogastroscopia is used to detect H. pylori infections that may contribute to anemia ferropénica<|>6)\n##\n(\"relationship\"<|>H. PYLORI<|>FIBROCOLONOSCOPIA<|>Fibrocolonoscopia may be used to investigate gastrointestinal issues related to H. pylori<|>5)\n##\n(\"relationship\"<|>SULFATO FERROSO<|>ANEMIA FERROPÉNICA<|>Sulfato ferroso is a treatment option for anemia ferropénica, helping to increase iron levels<|>9)\n##\n(\"relationship\"<|>TOMOGRAFÍA COMPUTARIZADA<|>FIBROGASTROSCOPIA<|>Tomografía computarizada may be used as an alternative diagnostic tool when fibrogastroscopia is not feasible<|>4)\n##\n(\"relationship\"<|>TOMOGRAFÍA COMPUTARIZADA<|>FIBROCOLONOSCOPIA<|>Tomografía computarizada can assist in diagnosing conditions that may also require fibroc colonoscopia<|>4)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: rica baja1, 15. El aumento en plasma del receptor soluble de la transferrina (TfR) y el índice TfR/log (ferritina)16 traduce la situación de ferropenia y es útil en el diagnóstico diferencial con la anemia de las enfermedades crónicas, donde estos parámetros son normales. La hemoglobina glicosilada puede aumentar en la anemia ferropénica e inducir a error en el seguimiento de pacientes diabéticos. Puede haber trombocitosis de grado moderado, sobre todo en caso de hemorragia activa.\n\nDebe insistirse en la importancia de detectar la causa que ocasiona la pérdida de hierro. Esta valoración debe llevarse a cabo antes de iniciar el tratamiento para no distorsionar el resultado de la misma. El estudio del tubo digestivo, salvo contraindicaciones, se hará mediante fibrogastroscopia y/o fibrocolonoscopia. La fibrogastroscopia debe incluir biopsia gástrica, detección de H. pylori y biopsia de la segunda porción del duodeno (para el despistaje de la enfermedad celíaca). Para el intestino delgado se puede emplear la cápsula endoscópica. Cuando no se pueda realizar endoscopia se puede recurrir, según el tramo, a la colonoscopia virtual realizada mediante tomografía computarizada, al enema opaco o al tránsito esofagogastroduodenal e intestinal17, 18.\n\n1.6. Tratamiento y prevención\n\nEl tratamiento consiste en conocer y tratar la causa desencadenante y aportar la cantidad de hierro necesaria para corregir la anemia y rellenar los depósitos3, 19. El hierro puede ser administrado por vía oral o parenteral. En casos de anemia ferropénica severa, el aporte\n---\n412      BLOQUE: METABOLISMO\n\nde hierro produce un aumento intenso de la eritropo-\nyesis, originando un consumo importante de ácido fó-\nlico que puede llegar a limitar la recuperación de la\nanemia. Por este motivo se recomienda profilaxis con\nunos 5 mg al día de ácido fólico.\n\nVía oral: Dosis de 80-105 mg/día de hierro elemen-\nto, en una o dos tomas diarias en función del grado de\nanemia. De elección el sulfato ferroso (hierro no hemo\nFe2+), que debe administrarse preferentemente 1 hora\nantes o 3 después de las comidas, ya que su absorción\nse puede reducir hasta un 50% con la ingesta de ciertas\nsustancias como calcio, fosfatos, fitatos, fenoles, etc.\nTambién se aconseja ingerir el suplemento acompaña-\ndo de cítricos para aumentar su absorción, al favorecer\nla conservación del hierro no hemo en su forma reduci-\nda (Fe2+). Una vez alcanzados los valores normales de\nhemoglobina y hematocrito, debe proseguirse el trata-\nmiento durante 3 meses hasta conseguir reponer los\ndepósitos (ferritina). Los controles analíticos deben rea-\nlizarse cada 7 días si la hemoglobina es menor de 7 g/dl,\ny cada 30 días si es mayor. Ha de plantearse un trata-\nmiento de mantenimiento si la causa persiste. Las cau-\nsas de un fracaso en el tratamiento oral son: error diag-\nnóstico, incumplimiento terapéutico, falta de resolución\nde la causa primaria, malabsorción, dosis o tipo de hie-\nrro inadecuados e intolerancia al hierro oral, que es la\ncausa más frecuente de fracaso terapéutico, principal-\nmente por alteraciones gastrointestinales, que pueden\nmejorar con la toma de hierro en las comidas pero a\ncosta de una menor absorción. El cribado de la enfer-\nmedad celíaca y la infección por H. pylori es obligado\ncuando la respuesta es inadecuada.\n\nLa suplementación de hierro semanal en mujeres en\nedad fértil durante un período largo es más eficaz y\nmejor tolerada que la suplementación diaria durante\nun período breve.\n\nLos suplementos de hierro pueden interferir en la ab-\nsorción de levotiroxina y levodopa.\n\nLos inhibidores de la bomba de protones como lan-\nsoprazol y omeprazol disminuyen el ácido gástrico, re-\nduciendo el hierro no hemo absorbido, y los suplemen-\ntos de calcio interfieren principalmente con la absorción\ndel hierro hemo. Este problema puede evitarse toman-\ndo los diferentes fármacos y el hierro separados en dis-\ntintos momentos del día.\n\nVía parenteral20: El tratamiento parenteral con hierro\nes eficaz pero más caro y con más riesgo de efectos ad-\nversos. Actualmente se dispone de diversos preparados\nde administr\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}